Status:

COMPLETED

Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Lead Sponsor:

Galderma R&D

Conditions:

Midface Volume Deficit

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a randomized, evaluator-blinded, no-treatment controlled study in subjects with Midface Volume Deficit and/or Midface Contour Deficiency.

Eligibility Criteria

Inclusion

  • Signed informed consent
  • Men or women aged 18 years of age or older of Chinese origin
  • Subjects willing to abstain from any other facial plastic surgical or cosmetic procedures below the level of the lower orbital rim for the duration of the study
  • Subjects seeking augmentation therapy for the midface
  • MMVS score of 2, 3 or 4 on each side of the face as assessed by the blinded evaluator

Exclusion

  • Known/previous allergy or hypersensitivity to any injectable HA gel/local anaesthetics, e.g.lidocaine or other amide-type anaesthetics.
  • Previous surgery or tattoo in the area to be treated
  • Previous tissue augmentation therapy or contouring with any permanent (non-biodegradable) or semi-permanent filler, autologous fat, lifting threads or permanent implant below the level of the lower orbital rim.
  • Previous use of any hyaluronic acid based or collagen based biodegradable facial tissue augmentation therapy below the level of the lower orbital rim or neurotoxin within 9 months before treatment.
  • Scars or deformities, active skin disease, inflammation or related conditions, such as infection, perioral dermatitis, seborrheic eczema, rosacea, acne psoriasis and herpes zoster near or in the area to be treated.
  • Other condition preventing the subject from entering the study in the Investigator's opinion.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2019

Estimated Enrollment :

168 Patients enrolled

Trial Details

Trial ID

NCT03289052

Start Date

December 1 2017

End Date

July 31 2019

Last Update

May 12 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Q-Med AB

Shanghai, China